Plus   Neg

Credit Suisse To Post Net Loss In Q4 - Quick Facts

Credit Suisse (CS) said it expects to increase provisions for the MBIA case and other RMBS-related cases by a total of $850 million. This charge will be reflected in the company's fourth quarter results. As a consequence of this increase, together with the expected impairment charge in respect of the non-controlling interest in York Capital Management, the company projects a net loss in fourth quarter.

The company noted that its trading performance in the final month of 2020 continued at similar levels to those summarized at Investor Update on December 15, 2020.

The Board has decided that the Annual General Meeting of Credit Suisse Group AG on April 30, 2021, will be held without the physical attendance of shareholders.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT